London, United KingdomFounded 20197+ employeesPrivate
$3.3M raisedSeed· last: seed (Jul 2022)· 4 rounds
Backed by(8 investors)
Initialized Capital · Lead+7 more
Mable is a personalized migraine clinic using DNA to find and provide the right medication alongside continuous expert care Using our approach, patients have an 80% higher treatment satisfaction rate, have one extra day per week to enjoy their life and get 55% pain reduction.
